Item 8.01. Other Events. On February 10, 2025, Iovance Biotherapeutics, Inc. (the “ Company”) issued a press release announcing the appointment of Daniel Kirby as Chief Commercial Officer. The full text of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Description No. 99.1 Press release dated February 10, 2025. ─────────────────────────────────────────────────────── SIGNATURES